You are here

Women's Imaging

 

A new study conducted by researchers from the University of Chicago Medicine and the University of Washington, Seattle has demonstrated that young women at a genetically high risk of developing breast cancer would benefit more receiving bi-annual MRI exams rather than standard annual mammogram.  

Being overweight is associated with a host of deleterious effects for an individual’s health, including increased risk for hypertension, cardiovascular disease and diabetes. Now, research presented Nov. 27 at RSNA 2017 connected difficulties in detecting breast cancer in women with higher body mass indexes (BMI).  

HER2-positive breast-cancer patients are safely and effectively imaged with PET/CT after being infused with a solution based on the radiotracer pertuzumab, according to a study published online Nov. 16 in the Journal of Nuclear Medicine.

Diffusion-weighted MRI (DWI) may soon command broader consideration than it’s been getting as a supplemental breast-screening tool. The modality not only finds many breast cancers that don’t show up on mammograms but also outperformed supplemental breast ultrasound in a study published online Oct. 28 in Clinical Imaging.

The U.S. Food and Drug Administration (FDA) issued an Oct. 27 reminder that thermography is not an acceptable substitute for mammography.

 

Recent Headlines

Bi-annual MRI more effective than mammograms for high-risk young women

A new study conducted by researchers from the University of Chicago Medicine and the University of Washington, Seattle has demonstrated that young women at a genetically high risk of developing breast cancer would benefit more receiving bi-annual MRI exams rather than standard annual mammogram.  

3D mammography is costly—but its benefits may more than pay the difference

While digital breast tomosynthesis (DBT), also known as 3D mammography, may cost more than digital mammography (DM) screenings at first, researchers believe it could reduce cancer screening costs in the long run. Findings were presented at the 2017 San Antonio Breast Cancer Symposium.

RSNA 2017: Alternative approach to mammography shows promise

Dense breast tissue presents problems for detecting cancer—often leading to additional screenings after negative or questionable mammograms. But at RSNA 2017 in Chicago, a research team discussed abbreviated breast MRI (AB-MR), a new method to screen asymptomatic women with dense breasts.

RSNA 2017: Breast tumors may be more difficult to detect in overweight women

Being overweight is associated with a host of deleterious effects for an individual’s health, including increased risk for hypertension, cardiovascular disease and diabetes. Now, research presented Nov. 27 at RSNA 2017 connected difficulties in detecting breast cancer in women with higher body mass indexes (BMI).  

PET/CT with new agent proves safe, successful in targeted breast imaging

HER2-positive breast-cancer patients are safely and effectively imaged with PET/CT after being infused with a solution based on the radiotracer pertuzumab, according to a study published online Nov. 16 in the Journal of Nuclear Medicine.

MRI technique beats breast ultrasound at supplemental screening

Diffusion-weighted MRI (DWI) may soon command broader consideration than it’s been getting as a supplemental breast-screening tool. The modality not only finds many breast cancers that don’t show up on mammograms but also outperformed supplemental breast ultrasound in a study published online Oct. 28 in Clinical Imaging.

FDA: Thermography is not an alternative to mammography

The U.S. Food and Drug Administration (FDA) issued an Oct. 27 reminder that thermography is not an acceptable substitute for mammography.

Latinas tend to prefer fixed-site over mobile mammography—but many come around with education, experience

Screening mammography providers “on wheels” planning to serve medically underserved Latino communities would do well to first communicate with each community on perceptions of such services and, where needed, to offer education prior to rolling in.

Dense-breast patients nearly 10 times more likely to pursue ABUS after 2-part notification

Following screening mammography that turns up nothing, women with dense breast tissue are much more likely to pursue additional imaging with automated breast ultrasound (ABUS) when two things happen: their radiologists inform them of their tissue density and encourage them to consider the secondary exam because of it.

Research aims to improve mammography quality, control dosing

Image quality in mammography, thanks to concerns about radiation dose, faces a Goldilocks problem—where radiologists want to get the best image possible, while also minimizing risk to the patient. 

Pages